142 related articles for article (PubMed ID: 34139975)
1. Pyrazole Substituted 9-Anilinoacridines as HER2 Inhibitors Targeting Breast Cancer - An in-silico approach.
Rajagopal K; Sri VB; Byran G; Gomathi S
Curr Drug Res Rev; 2022; 14(1):61-72. PubMed ID: 34139975
[TBL] [Abstract][Full Text] [Related]
2. In-silico Design, ADMET Screening, MM-GBSA Binding Free Energy of Some Novel Isoxazole Substituted 9-Anilinoacridines as HER2 Inhibitors Targeting Breast Cancer.
Kalirajan R; Pandiselvi A; Gowramma B; Balachandran P
Curr Drug Res Rev; 2019; 11(2):118-128. PubMed ID: 31513003
[TBL] [Abstract][Full Text] [Related]
3. In-silico Design, ADMET Screening, Prime MM-GBSA Binding Free Energy Calculation and MD Simulation of Some Novel Phenothiazines as 5HT6R Antagonists Targeting Alzheimer's Disease.
V P; A M; N R
Curr Comput Aided Drug Des; 2024 Jan; ():. PubMed ID: 38204222
[TBL] [Abstract][Full Text] [Related]
4. Identification of some novel oxazine substituted 9-anilinoacridines as SARS-CoV-2 inhibitors for COVID-19 by molecular docking, free energy calculation and molecular dynamics studies.
Rajagopal K; Varakumar P; Aparna B; Byran G; Jupudi S
J Biomol Struct Dyn; 2021 Sep; 39(15):5551-5562. PubMed ID: 32720578
[TBL] [Abstract][Full Text] [Related]
5. Identification of tyrosine kinase inhibitors from Panax bipinnatifidus and Panax pseudoginseng for RTK-HER2 and VEGFR2 receptors, by in silico approach.
Paul D; Mahanta S; Tag H; Das SK; Das Gupta D; Tanti B; Ananthan R; Das R; Jambhulkar S; Hui PK
Mol Divers; 2022 Aug; 26(4):1933-1955. PubMed ID: 34554395
[TBL] [Abstract][Full Text] [Related]
6. An
Malkaje S; Srinivasa MG; Deshpande N S; Navada S; Revanasiddappa Bc
Curr Drug Res Rev; 2023; 15(1):88-100. PubMed ID: 36017854
[TBL] [Abstract][Full Text] [Related]
7.
Rajagopal K; Kalusalingam A; Bharathidasan AR; Sivaprakash A; Shanmugam K; Sundaramoorthy M; Byran G
Molecules; 2023 May; 28(10):. PubMed ID: 37241915
[TBL] [Abstract][Full Text] [Related]
8. Identification of HER2 inhibitors from curcumin derivatives using combination of
Saibu OA; Singh G; Olugbodi SA; Oluwafemi AT; Ajayi TM; Hammed SO; Oladipo OO; Odunitan TT; Omoboyowa DA
J Biomol Struct Dyn; 2023; 41(21):12328-12337. PubMed ID: 36752338
[TBL] [Abstract][Full Text] [Related]
9. Virtual Screening of Novel Glucosamine-6-Phosphate Synthase Inhibitors.
Lather A; Sharma S; Khatkar A
Comb Chem High Throughput Screen; 2018; 21(3):182-193. PubMed ID: 29600755
[TBL] [Abstract][Full Text] [Related]
10. A Computational Study of Phenothiazine Derivatives as Acetylcholinesterase Inhibitors Targeting Alzheimer's Disease.
V P; A P; N P
Cent Nerv Syst Agents Med Chem; 2024 May; ():. PubMed ID: 38757327
[TBL] [Abstract][Full Text] [Related]
11. In-silico screening and molecular dynamics simulation of quinazolinone derivatives as PARP1 and STAT3 dual inhibitors: a novel DML approaches.
Dilipkumar S; Karthik V; Dk S; Gowramma B; Lakshmanan K
J Biomol Struct Dyn; 2023 Sep; ():1-11. PubMed ID: 37735921
[TBL] [Abstract][Full Text] [Related]
12. Exploring the Potential of Natural Products as FoxO1 Inhibitors: an
Gupta A; Haldhar R; Agarwal V; Rajput DS; Chun KS; Han SB; Raj V; Lee S
Biomol Ther (Seoul); 2024 May; 32(3):390-398. PubMed ID: 38586882
[TBL] [Abstract][Full Text] [Related]
13. Discovery of potential HER2 inhibitors from
Balogun TA; Iqbal MN; Saibu OA; Akintubosun MO; Lateef OM; Nneka UC; Abdullateef OT; Omoboyowa DA
J Biomol Struct Dyn; 2022; 40(23):12772-12784. PubMed ID: 34514973
[TBL] [Abstract][Full Text] [Related]
14. Thymoquinone and its derivatives against breast cancer with HER2 positive:
Wulandari AA; Choiri AA; Fitria ; Widiandani T
J Basic Clin Physiol Pharmacol; 2021 Jun; 32(4):393-401. PubMed ID: 34214298
[TBL] [Abstract][Full Text] [Related]
15. In-silico Design and ADMET Studies of Natural Compounds as Inhibitors of Xanthine Oxidase (XO) Enzyme.
Malik N; Dhiman P; Khatkar A
Curr Drug Metab; 2017; 18(6):577-593. PubMed ID: 28302027
[TBL] [Abstract][Full Text] [Related]
16. Benzothiazole derivatives as p53-MDM2 inhibitors:
N SD; Shivakumar ; Kumar D U; Ghate SD; Dixit SR; Awasthi A; Revanasiddappa BC
J Biomol Struct Dyn; 2023 Dec; ():1-12. PubMed ID: 38111168
[TBL] [Abstract][Full Text] [Related]
17. An in silico approach for identification of lead compound as FtsZ inhibitor.
Kifayat S; Almuqdadi HTA; Singh RP; Singh M; Abid M; Sanapalli BKR
Mol Divers; 2024 May; ():. PubMed ID: 38775995
[TBL] [Abstract][Full Text] [Related]
18. The potential of some functional group compounds substituted 8-Manzamine A as RSK1 inhibitors: molecular docking and molecular dynamics simulations.
Zayed AOH; Altarabeen M; AlShamaileh E; Zain SM
J Biomol Struct Dyn; 2024 Feb; ():1-10. PubMed ID: 38319051
[TBL] [Abstract][Full Text] [Related]
19. Activity of phytochemical constituents of
Rajagopal K; Varakumar P; Baliwada A; Byran G
Futur J Pharm Sci; 2020; 6(1):104. PubMed ID: 33215042
[TBL] [Abstract][Full Text] [Related]
20. Artonin E and Structural Analogs from Artocarpus Species Abrogates Estrogen Receptor Signaling in Breast Cancer.
Etti I; Abdullah R; Hashim NM; Kadir A; Abdul AB; Etti C; Malami I; Waziri P; How CW
Molecules; 2016 Jun; 21(7):. PubMed ID: 27367662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
